182 related articles for article (PubMed ID: 33480074)
1. Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25
Chen Z; Yang Y; Neo SY; Shi H; Chen Y; Wagner AK; Larsson K; Tong L; Jakobsson PJ; Alici E; Wu J; Cao Y; Wang K; Liu LL; Mao Y; Sarhan D; Lundqvist A
EMBO Rep; 2021 Mar; 22(3):e51329. PubMed ID: 33480074
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis.
Walker W; Rotondo D
Immunology; 2004 Mar; 111(3):298-305. PubMed ID: 15009430
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
Front Immunol; 2018; 9():1859. PubMed ID: 30140269
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression
Schmetterer KG; Goldhahn K; Ziegler LS; Gerner MC; Schmidt RLJ; Themanns M; Zebedin-Brandl E; Trapin D; Leitner J; Pickl WF; Steinberger P; Schwarzinger I; Marculescu R
Front Immunol; 2019; 10():1790. PubMed ID: 31417563
[TBL] [Abstract][Full Text] [Related]
6. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
7. CD25
Chen Z; Tong L; Neo SY; Li S; Gao J; Schlisio S; Lundqvist A
Oncoimmunology; 2023; 12(1):2175517. PubMed ID: 36970070
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation.
Van Elssen CH; Vanderlocht J; Oth T; Senden-Gijsbers BL; Germeraad WT; Bos GM
Blood; 2011 Sep; 118(9):2473-82. PubMed ID: 21715307
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
Goto T; Herberman RB; Maluish A; Strong DM
J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.
Leung KH
Cell Immunol; 1989 Oct; 123(2):384-95. PubMed ID: 2507171
[TBL] [Abstract][Full Text] [Related]
14. Modulation of human NK cells by interferon and prostaglandin E2.
Koren HS; Leung KH
Mol Immunol; 1982 Oct; 19(10):1341-6. PubMed ID: 6184617
[TBL] [Abstract][Full Text] [Related]
15. Glutamine suppresses PGE2 synthesis and breast cancer growth.
Klimberg VS; Kornbluth J; Cao Y; Dang A; Blossom S; Schaeffer RF
J Surg Res; 1996 Jun; 63(1):293-7. PubMed ID: 8661213
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
18. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2.
Malygin AM; Meri S; Timonen T
Scand J Immunol; 1993 Jan; 37(1):71-6. PubMed ID: 8380302
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by cortisol of human natural killer (NK) cell activity.
Gatti G; Cavallo R; Sartori ML; del Ponte D; Masera R; Salvadori A; Carignola R; Angeli A
J Steroid Biochem; 1987 Jan; 26(1):49-58. PubMed ID: 2434732
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
